Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion type Assertion NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_head.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion evidence source_evidence_literature NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion SIO_000772 14585257 NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion wasDerivedFrom befree-2016 NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion wasGeneratedBy ECO_0000203 NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.